{
    "title": "Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10724031/Omicron-specific-Sinopharm-Sinovac-COVID-vaccine-candidates-cleared-clinical-trial.html",
    "date": "2022-04-16",
    "keywords": [
        "vaccine",
        "dose",
        "sinovac",
        "omicron",
        "subsidiary",
        "cnbg",
        "sinopharm",
        "booster",
        "antibody",
        "biotech",
        "variant",
        "hong",
        "activity",
        "biotec",
        "group",
        "contain",
        "coronavirus",
        "china",
        "trial",
        "coronavac",
        "protection",
        "study",
        "httpswwwmedrxivorgcontent1011012022021922271215v1fullpdf",
        "bbibpcorv",
        "covid",
        "alternative",
        "roxanne",
        "liu",
        "andrew",
        "galbraith",
        "editing",
        "edmund",
        "klamann",
        "mallard"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}